NutraIngredients.com Newsletter

If you are unable to view this message correctly, click here


News & Analysis on Supplements, Health & Nutrition - Europe

16-Feb-2023

Special Edition: CBD

CBD food products are now considered 'novel' and need to be assessed for safety before being placed on the market in Europe.Â Novel Food regulation is confusing enough without the additional complication caused by Brexit, making the process divided between EFSA (in Europe) and the FSA (in the UK). That said, both markets are seeing large amounts of innovation at the same time as increased legal scrutiny.Â This special newsletter provides some market insights from experts along with recent scientific research.

What next for CBD products in Europe? âI would not dare make a predictionâ, says expert

With more than 400 products recently being removed from the FSAâs public list of CBD novel food applications, the retail market should be in the midst of major change, but what should be happening and what is happening are two different discussions in the world of CBD... Read

ESSNA insights: CBD developments for the sports nutrition industry

The number of sports and active nutrition companies investing in CBD has grown significantly in Europe over the last few years despite regulatory uncertainty, so what does this market hold for these brands? In this article, ESSNAâs Chair Dr Adam Carey, gives his insights... Read

"Consider drops of CBD information to predict where the dam will break"

In this guest article, regulatory consultant Stephen Oliver, co-founder of The Canna Consultants, provides his view of the CBD market in 2023... Read

Study: CBD may lower blood pressure in hypertensive patients

After five-weeks of CBD administration to hypertensive patients, reductions in blood pressure were paired with significant drops in the catestatin peptides involved in hypertension pathophysiology, a randomised controlled trial observes... Read

âRocky timeâ for CBD industry leads to casualties in âgood brandsâ

An elite-athlete turned CBD supplement brand founder has described the ârockyâ road travelled in this fast-evolving market but says he ultimately looks forward to an âextremely excitingâ future... Read

Potential for CBD to treat traumatic brain injuries, review concludes

Cannabidiol (CBD) shows strong potential for its inclusion in clinical treatment of traumatic brain injuries (TBI), with mechanisms of action including the mediation of the cellular and biochemical changes associated with the injuries, a recent literature review concludes... Read

Study champions CBD with THC for insomnia

A broad-spectrum medicinal cannabis oil is effective in significantly improving sleep quality and duration, midnight melatonin levels, as well as quality of life and mood within two weeks, in adults with insomnia, according to new research... Read